LSDMescalineMDMAPsilocybinIbogaineDMT

The psychopharmacology of hallucinogens

This review paper (1996) examines the history and epidemiology of hallucinogens (LSD, Mescaline, MDM, MDMA, Psilocybin, Ibogaine, Harmine, and DMT) with respect to their psychotic effects, hallucinogen persisting perception disorder, and therapeutic efficacy. Representative studies include 13 publications on LSD therapy to treat alcoholism (n=1409), and 16 studies on post-LSD psychoses (n=75).

Authors

  • Abraham, H. D.
  • Aldridge, A. M.
  • Gogia, P.

Published

Neuropsychopharmacology
meta Study

Abstract

Review: Hallucinogenic drugs have been inhaled, ingested, worshipped, and reviled since prehistory. With the purification and synthesis of bontanical preparations and the ensuing discovery of chemically unique agents, hope was raised regarding their therapeutic potential, but this hope has been clouded by an epidemic of abuse and an inventory of adverse effects. This review examines aspects of that controversy, including the history of hallucinogens, epidemiology of current hallucinogen abuse, the association of LSD use with prolonged psychoses and hallucinogen persisting perception disorder, and the efforts to demonstrate the drug's therapeutic efficacy.Discussion: Human subject ramifications in hallucinogen experimentation are discussed. Future lines of research are suggested in human, animal, and tissue culture paradigms.

Unlocked with Blossom Pro

Research Summary of 'The psychopharmacology of hallucinogens'

Full Text PDF

Open PDF in new tab

Study Details

Cited By (25)

Papers in Blossom that reference this study

New insights into the clinical and nonclinical effects of psychedelic substances: An integrative review.

Forstmann, M., Sagioglou, C. · European Psychologist (2022)

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants

Becker, A. M., Borgwardt, S., Holze, F. et al. · Psychopharmacology (2022)

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Barrett, F. S., Griffiths, R. R., Hendricks, P. S. et al. · Pharmacology and Therapeutics (2019)

Metabolism of lysergic acid diethylamide (LSD): an update

Libânio Osório Marta, R. F. · Drug Metabolism Reviews (2019)

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

Schenberg, E. E. · Frontiers in Pharmacology (2018)

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives

Giannantonio, M. D., Lerner, A. G., Lorusso, M. et al. · Brain Sciences (2018)

Phenomenology, Structure, and Dynamic of Psychedelic States

Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

A Public-Health-Based Vision for the Management and Regulation of Psychedelics

Emerson, B., Haden, M., Tupper, K. W. · Journal of Psychoactive Drugs (2016)

28 cited
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years

Crippa, J. A., Dos Santos, R. G., Hallak, J. E. et al. · Therapeutic Advances in Psychopharmacology (2016)

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

Crippa, J. A., Dos Santos, R. G., Hallak, J. E. et al. · brazilian Journal of Psychiatry (2016)

Show all 25 papers
New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations

Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Psychedelic medicine: a re-emerging therapeutic paradigm

Johnson, M. W., Tupper, K. W., Wood, E. et al. · Canadian Medical Association Journal (2015)

Acute effects of lysergic acid diethylamide in healthy subjects

Borgwardt, S., Brenneisen, R., Enzler, F. et al. · Biological Psychiatry (2015)

LSD-associated “Alice in Wonderland Syndrome”(AIWS): A Hallucinogen Persisting Perception Disorder (HPPD) Case Report

Lerner, A. G. · The Israel Journal of Psychiatry and Related Sciences; Jerusalem (2015)

Flashbacks and HPPD: A Clinical-oriented Concise Review

Bor, O., Goodman, C., Lerner, A. G. et al. · The Israel Journal of Psychiatry and Related Sciences; Jerusalem (2014)

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Jesse, R., Johnson, M. W. et al. · Psychopharmacology (2011)

Harm potential of magic mushroom use: A review

Opperhuizen, A., van Amsterdam, J., van den Brink, W. · Regulatory Toxicology and Pharmacology (2011)

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

Griffiths, R. R., Jesse, R., Johnson, M. W. et al. · Journal of Psychopharmacology (2008)

The behavioral pharmacology of hallucinogens

Fantegrossi, W. E., Murnane, K. S., Reissig, C. J. · Biochemical Pharmacology (2007)

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Jesse, R., McCann, U. D. et al. · Journal of Psychopharmacology (2006)

Flashback: psychiatric experimentation with LSD in historical perspective

Dyck, E. · Canadian Journal of Psychiatry (2005)

Hallucinogens

Nichols, D. E. · Pharmacology and Therapeutics (2004)

Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features

Bleich, A., Gelkopf, M., Nachshon, H. et al. · International Clinical Psychopharmacology (2003)

Hallucinogen persisting perception disorder: what do we know after 50 years?

Halpern, J. H., Pope Jr, H. G. · Drug and Alcohol Dependence (2003)

Your Library